AspenBio Pharma, Inc. (APPY) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 67 transactions totaling $1.1M, demonstrating a bearish sentiment with -$24.4K in net insider flow. The most recent transaction on Dec 1, 2016 involved a purchase of 18,731 shares valued at $94.6K.
No significant insider buying has been recorded for APPY in the recent period.
No significant insider selling has been recorded for APPY in the recent period.
Based on recent SEC filings, insider sentiment for APPY is bearish with an Insider Alignment Score of 49/100 and a net flow of -$24.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AspenBio Pharma, Inc. (APPY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading APPY stock, having executed 67 transactions in the past 90 days. The most active insider is Douglas I. Hepler (Executive), who has made 30 transactions totaling $594.5K.
Get notified when executives and directors at APPY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 1, 2016 | C. Honig Barry | Executive | Purchase | 18,731 | $5.05 | $94.6K | |
| Dec 1, 2016 | C. Honig Barry | Executive | Purchase | 1,600 | $5.00 | $8.0K | |
| Dec 1, 2016 | C. Honig Barry | Executive | Purchase | 1,000 | $5.30 | $5.3K | |
| Dec 1, 2016 | C. Honig Barry | Executive | Purchase | 1,000 | $5.32 | $5.3K | |
| Dec 1, 2016 | C. Honig Barry | Executive | Purchase | 7,484 | $4.95 | $37.0K | |
| Oct 19, 2016 | C. Honig Barry | Executive | Purchase | 6,086 | $2.78 | $16.9K | |
| Oct 18, 2016 | C. Honig Barry | Executive | Purchase | 13,400 | $2.68 | $35.9K | |
| Oct 13, 2016 | C. Honig Barry | Executive | Purchase | 28,935 | $2.28 | $66.0K | |
| Oct 6, 2016 | C. Honig Barry | Executive | Purchase | 12,777 | $2.71 | $34.6K | |
| Sep 30, 2016 | C. Honig Barry | Executive | Purchase | 2,228 | $2.80 | $6.2K | |
| Apr 14, 2014 | R. Hurd Donald | Executive | Purchase | 35,000 | $2.04 | $71.4K | |
| Sep 21, 2012 | R. Hurd Donald | Executive | Purchase | 15,000 | $1.99 | $29.9K | |
| Aug 3, 2012 | Schoettler Gail | Executive | Purchase | 2,500 | $1.58 | $4.0K | |
| Jun 29, 2012 | Pusey Gregory | Executive | Purchase | 2,000 | $1.94 | $3.9K | |
| Jun 29, 2012 | Lundy Steve | Executive | Purchase | 4,000 | $1.93 | $7.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 29 | $557.0K | 44.5% |
Purchase(P) | 28 | $532.6K | 42.5% |
Gift(G) | 1 | $125.4K | 10.0% |
Exercise(M) | 1 | $37.5K | 3.0% |
Other(J) | 8 | $0 | 0.0% |
Insider activity at AspenBio Pharma, Inc. shows mixed signals across all time. While $532.6K in purchases indicates some executive confidence,$557.0K in sales balances the picture, resulting in a modest net flow of -$24.4K.11 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Douglas I. Hepler, has transacted $594.5K during this period.